Retinal masqueraders of optic nerve disease

Ophthalmology Clinics of North America

Volumn 14, Issue 1, 2001, Pages 41-59

  Sandbach, J M ^a   Newman, N J ^a  

^a EMORY EYE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; DEFEROXAMINE; DIGOXIN; HYDROXYCHLOROQUINE; QUININE; THIORIDAZINE; VIGABATRIN;

ADULT; AGED; AUTOFLUORESCENCE; CHORIORETINOPATHY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DIFFERENTIAL DIAGNOSIS; ELECTROPHYSIOLOGY; FEMALE; FLUORESCENCE ANGIOGRAPHY; HUMAN; INDOCYANINE GREEN ANGIOGRAPHY; MALE; NIGHT BLINDNESS; OPHTHALMOSCOPY; OPTIC NERVE DISEASE; PRIORITY JOURNAL; RETINA DISEASE; RETINA DYSTROPHY; RETINA MACULA DEGENERATION; RETINITIS PIGMENTOSA; RETINOL DEFICIENCY; RETINOPATHY; REVIEW; STARGARDT DISEASE;

DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; ELECTROPHYSIOLOGY; HUMANS; OPTIC NERVE DISEASES; RETINAL DISEASES;

EID: 0035028362     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (81)

1. A photoreceptor cell-specific ATP binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy
2. Comparison between optical coherence tomography and fundus fluorescein angiography for the detection of cystoid macular edema in patients with uveitis
3. S-cone ERGs elicited by a simple technique in normal and in tritanopes
4. Outer retinal dysfunction in patients treated with vigabatrin
5. Severe persistent visual field constriction associated with vigabatrin: Manufacturers have started several studies
6. Pharmacokinetics and clinical toxicity of quinine overdosage: Lack of efficacy of techniques intended to enhance elimination
7. Clinical applications of optical coherence tomography
8. Ophthalmic considerations and testing in patients receiving long-term antimalarial therapy
9. Retinitis pigmentosa and allied diseases: Electrophysiologic findings
10. Risk factors for genetic typing and detection in retinitis pigmentosa
11. Color plates to help identify patients with blue cone monochromatism
12. The visual evoked potential
13. Ocular quinine toxicity
14. Recommended standards for pattern electroretinograms and visual evoked potentials: The international federation of clinical neurophysiology
15. Paraneoplastic retinopathy simulating cone dystrophy with achromatopsia
16. Symptomatic and asymptomatic visual field loss in patients taking vigabatrin
17. Allergic vasculitis caused by vigabatrin
18. Clinical features of codon 172 RDS macular dystrophy: Similar phenotype in families
19. Death and blindness due to overdose of quinine
20. Severe persistent visual field constriction associated with vigabatrin
21. Terapia con vigabatrin nelle epilessie parziali resistenti
22. The focal electroretinogram in the clinical assessment of macular disease
23. Retinitis pigmentosa: Visual loss
24. The electro-oculogram
25. The electroretinogram in retinal disease
26. Standard for visual evoked potentials 1995: The international society for clinical electrophysiology of vision
27. Static perimetry in chloroquine retinopathy, perifoveal patterns of visual field depression
28. The pattern electroretinogram
29. A comparison of the components of the multifocal and full-field ERGs
30. Foveal cone dysfunction syndrome
31. Pattern of retinal dysfunction in acute AZOOR
32. Paraneoplastic diseases of neuroophthalmic interest
33. Paraneoplastic cone dysfunction syndrome: An unusual visual remote effect of cancer
34. MEWDS, MFC, AMN, AIBSE and AZOOR: One disease or many?
35. Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects
36. Multifocal ERG in chloroquine retinopathy; regional variance of retinal dysfunction
37. Multifocal ERG recording by the VERIS technique and its clinical applications
38. Familial macular cone dystrophy: Diagnostic value of multifocal ERG and two-color threshold perimetry
39. Dominant cone degenerations: The cone dystrophies
40. The cone degenerations
41. Visual field defects associated with vigabatrin therapy
42. Acute zonal outer occult retinopathy
43. Intrafamilial variation of phenotype in Stargardt macular dystrophy-fundus flavimaculatus
44. Electrophysiologic and ERG evidence for photoreceptor dysfunction as a toxic effect of digoxin
45. Multiple evanescent white-dot syndrome: A report of eight cases
46. Is thioridazine retinopathy progressive? Relationship of pigmentary changes to visual function
47. Guidelines for pattern electroretinography: Recommendations by the international society for clinical electrophysiology of vision
48. Central serous chorioretinopathy: Bilateral multifocal electroretinographic abnormalities
49. Standard for clinical electrooculography: International society for clinical electrophysiology of vision
50. Standard for clinical electroetinography (1994 update)
51. Foveal cone electroretinograms in patients with central visual loss of unexplained etiology
52. Visual dysfunction in patients receiving vigabatrin: Clinical and electrophysiological findings
53. Assessment of the retinal toxicity of hydroxychloroquine
54. Occult macular dystrophy
55. Hereditary macular dystrophy without visible fundus abnormality
56. Congenital stationary night blindness with negative electroretinogram: A new classification
57. Two year electrophysiology follow-up in quinine amblyopia: A case report
58. Indocyanine green videoangiography
59. Optic disc pallor: A false localizing sign
60. Cinical and subclinical ophthalmic findings with retinol deficiency
61. Indocyanine green angiographic aspects of multiple evanescent white dot syndrome
62. Retinitis pigmentosa
63. Multifocal electroretinogram in occult macular dystrophy
64. Occult retinitis pigmentosa simulating central nervous system disease
65. Occult retinal and choroidal vascular disease: The value of timed and directed fluorescein angiography
66. Idiopathic photoreceptor dysfunction causes unexplained visual acuity loss in later adulthood
67. Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin
68. Gastrointestinal and nutritional disorders
69. The field topography of ERG components in man: I. The photopic luminance response
70. Disorders of pupillary function, accommodation and lacrimation
71. Atypical retinitis pigmentosa masquerading as a nerve fiber bundle lesion
72. Reversibility of vigabatrin-induced visual-field defect
73. In vivo fundus autofluorescence in macular dystrophies
74. Retinal toxicity of systemic drugs
75. Foveal outer retinal function in eyes with unexplained visual symptoms or acuity loss
76. Digoxin retinal toxicity: Clinical and electrophysiologic evaluation of a cone dysfunction syndrome
77. Insights into the function of rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice
78. Neuro-ophthalmic presentation of cone dysfunction syndromes in the adult